Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 2855

BillFederalHouseIn Committee
To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.
About This Bill
Committee
Latest Action · May 21, 2019
Referred to the Subcommittee on Health.
Congress
116th (2019–2021)
Introduced
May 20, 2019
Cosponsors (0)
None
View PDF ↗

Summary

Highlight any text to annotate
This bill provides for approval of the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.